FR2341139A1 - Trousse de reactifs pour le dosage de l'adenosine-3', 5'-monophosphate cyclique et du guanosine-3', 5'-monophosphate cyclique - Google Patents

Trousse de reactifs pour le dosage de l'adenosine-3', 5'-monophosphate cyclique et du guanosine-3', 5'-monophosphate cyclique

Info

Publication number
FR2341139A1
FR2341139A1 FR7703742A FR7703742A FR2341139A1 FR 2341139 A1 FR2341139 A1 FR 2341139A1 FR 7703742 A FR7703742 A FR 7703742A FR 7703742 A FR7703742 A FR 7703742A FR 2341139 A1 FR2341139 A1 FR 2341139A1
Authority
FR
France
Prior art keywords
monophosphate
cyclic
determination
reagent kit
guanosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7703742A
Other languages
English (en)
Other versions
FR2341139B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Shoyu KK
Original Assignee
Yamasa Shoyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu KK filed Critical Yamasa Shoyu KK
Publication of FR2341139A1 publication Critical patent/FR2341139A1/fr
Application granted granted Critical
Publication of FR2341139B1 publication Critical patent/FR2341139B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7703742A 1976-02-12 1977-02-10 Trousse de reactifs pour le dosage de l'adenosine-3', 5'-monophosphate cyclique et du guanosine-3', 5'-monophosphate cyclique Granted FR2341139A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51014665A JPS5825980B2 (ja) 1976-02-12 1976-02-12 サイクリックヌクレオチドの定量法

Publications (2)

Publication Number Publication Date
FR2341139A1 true FR2341139A1 (fr) 1977-09-09
FR2341139B1 FR2341139B1 (fr) 1979-10-05

Family

ID=11867499

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7703742A Granted FR2341139A1 (fr) 1976-02-12 1977-02-10 Trousse de reactifs pour le dosage de l'adenosine-3', 5'-monophosphate cyclique et du guanosine-3', 5'-monophosphate cyclique

Country Status (7)

Country Link
US (1) US4115538A (fr)
JP (1) JPS5825980B2 (fr)
CA (1) CA1092022A (fr)
CH (1) CH618015A5 (fr)
DE (1) DE2705897C3 (fr)
FR (1) FR2341139A1 (fr)
GB (1) GB1527465A (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378344A (en) * 1979-09-28 1983-03-29 Ventrex Laboratories, Inc. Method and apparatus for performing multiple, simultaneous in vitro diagnostic tests using a solid phase system
US4433061A (en) * 1981-06-01 1984-02-21 American Hospital Supply Corporation Radioimmunoassay for cyclic nucleotides
JPS5811857A (ja) * 1981-07-15 1983-01-22 Yamasa Shoyu Co Ltd アデノシンの定量法
US5118607A (en) * 1989-10-23 1992-06-02 Hawaii Biotechnology Group, Inc. Non-aqueous solvent specific binding protein assays
CA2238283C (fr) * 1997-05-30 2002-08-20 Cell Pathways, Inc. Methode d'identification de composes visant a inhiber les lesions neoplasiques, compositions pharmaceutiques a prtir de ces composes et compositions pour traiter les lesions neoplasiques
US7402400B2 (en) 2001-07-03 2008-07-22 Regents Of The University Of California Mammalian sweet taste receptors
US6686171B2 (en) 1999-05-10 2004-02-03 Tropix, Inc. Competitive chemiluminescent assay for cyclic nucleotide monophosphates
US6794156B2 (en) 1999-05-10 2004-09-21 Applera Corporation Cell growth, induction and lysis in an antibody-coated microplate for use in an ELISA
TW201006846A (en) 2000-03-07 2010-02-16 Senomyx Inc T1R taste receptor and genes encidung same
TW201022287A (en) 2001-01-03 2010-06-16 Senomyx Inc T1R taste receptors and genes encoding same
US7883856B2 (en) 2001-04-05 2011-02-08 Senomyx Inc. Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
IL158488A0 (en) * 2001-04-20 2004-05-12 Sinai School Medicine Tir3 a novel taste receptor
US6809104B2 (en) * 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
US20070135425A1 (en) * 2001-05-04 2007-06-14 Amgen Inc. Fused heterocyclic compounds
EP2003451B1 (fr) 2001-06-26 2012-05-30 Senomyx, Inc. Récepteurs gustatifs umamis hétero-oligomères t1r1-t1r3, lignées cellulaires exprimant lesdits récepteurs et utilisation de ces récepteurs pour identifier des composés gustatifs umamis
JP2005522187A (ja) * 2001-10-12 2005-07-28 ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア サン ディエゴ 胃腸化学感覚受容体
EP1562943A1 (fr) * 2002-11-06 2005-08-17 Amgen Inc. Composes heterocycliques condenses
CA2900181C (fr) 2003-08-06 2019-01-29 Catherine Tachdjian Saveurs, modificateurs de saveur, agents gustatifs, rehausseurs de gout, agents gustatifs et/ou rehausseurs umami ou sucres, et utilisation correspondante
US20050244810A1 (en) * 2003-09-29 2005-11-03 Egan Josephine M Taste signaling in gastrointestinal cells
JP5342878B2 (ja) 2005-10-20 2013-11-13 セノミクス・インコーポレーテッド キメラヒト甘味‐旨味および旨味‐甘味味覚受容体
US20110097741A1 (en) * 2006-04-20 2011-04-28 Jay Patrick Slack Partial t1r2 nucleic acid sequence, receptor protein and its use in screening assays
EP2008095A1 (fr) * 2006-04-20 2008-12-31 Givaudan SA Procédé fonctionnel destiné à identifier des agents donnant du goût
WO2007121604A2 (fr) 2006-04-20 2007-11-01 Givaudan Sa Procédé destiné à améliorer un goût sucré
US8148536B2 (en) 2006-04-21 2012-04-03 Senomyx, Inc. Comestible compositions comprising high potency savory flavorants, and processes for producing them
WO2008086634A2 (fr) * 2007-01-18 2008-07-24 Givaudan Sa Acide nucléique, polypeptide et leur utilisation
US8187822B2 (en) 2007-03-30 2012-05-29 Givaudan S.A. Methods to identify modulators
EP2187902B1 (fr) 2007-08-01 2013-04-17 The General Hospital Corporation Procédés de criblage à récepteurs couplés à la protéine g et compositions apparentées
CA2696995C (fr) 2007-08-21 2017-11-21 Senomyx, Inc. Identification de recepteurs humains t2r sensibles aux composes amers qui provoquent le gout amer dans des compositions, et utilisation de ceux-ci dans des analyses d'identification de composes qui inhibent (bloquent) le gout amer dans des compositions et utilisation de celles-ci
WO2010037001A2 (fr) 2008-09-26 2010-04-01 Immune Disease Institute, Inc. Oxydation sélective de 5-méthylcytosine par des protéines de la famille tet
EP2376101B1 (fr) * 2008-12-29 2015-12-02 Trevena, Inc. Effecteurs de la beta-arrestine, compositions en contenant et leurs procédés d'utilisation
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
US8828953B2 (en) * 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
AU2010239311B2 (en) 2009-04-20 2014-05-22 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
EP2567229A1 (fr) 2010-05-07 2013-03-13 Givaudan SA Procédé pour identifier des modulateurs
SG184962A1 (en) 2010-05-07 2012-11-29 Givaudan Sa Methods to identify modulators of tas2r4s receptors
EP2630491A4 (fr) 2010-10-19 2014-08-27 Elcelyx Therapeutics Inc Thérapies basées sur un ligand de récepteur chimiosensoriel
US20120177730A1 (en) 2011-01-07 2012-07-12 Elcelyx Therapeutics, Inc. Chemosensory Receptor Ligand-Based Therapies
SI2688403T1 (sl) 2011-03-23 2017-08-31 Trevena, Inc. Ligandi opioidnih receptorjev in metode uporabe in izdelave istega
US9128079B2 (en) 2011-08-08 2015-09-08 The Coca-Cola Company Methods of using lung or bronchial epithelial cells to identify bitter taste modulators
WO2013022947A1 (fr) 2011-08-08 2013-02-14 The Coca-Cola Company Lignées cellulaires comprenant des récepteurs endogènes du goût et leurs utilisations
CN104168907A (zh) 2012-01-31 2014-11-26 特维娜有限公司 β-抑制蛋白效应器及其组合物与使用方法
WO2013158928A2 (fr) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Thérapies à base de ligand de récepteur chimiosensoriels
NZ710444A (en) 2013-02-11 2020-08-28 Univ California Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
BR112015023737A2 (pt) 2013-03-15 2017-10-24 Applied Food Biotech Inc polipeptídeo do receptor felino tas2r isolado (ftas2r), composição, polinucleotídeo isolado, par de iniciadores, vetor de expressão, célula hospedeira, cultura celular, oligonucleotídeo, anticorpo isolado ou um fragmento desse, método para identificar um composto que interage com um polipeptídeo do receptor felino tas2r, método para identificar um composto que modula um polipeptídeo do receptor felino tas2r, método para preparar uma composição comestível, método para formular uma composição comestível com palatabilidade intensificada, método para administrar um composto amargo a um animal que necessita desse, método para preparar uma composição comestível para controlar a palatabilidade da composição comestível para um animal, método para produzir uma composição de sabor para revestimento ou incorporação em uma composição comestível a ser administrada para um animal, e composição de sabor para revestimento ou incorporação em uma composição comestível a ser administrada para um animal
JP2017506235A (ja) 2014-02-07 2017-03-02 トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． ベータ−アレスチンエフェクターの結晶性および非晶質形態
WO2015123365A1 (fr) 2014-02-11 2015-08-20 Mitokinin Llc Compositions et procedes les utilisant pour le traitement de maladie neurodegenerative et mitochondriale
AU2015264367A1 (en) 2014-05-19 2016-12-15 Trevena, Inc. Synthesis of Beta-Arrestin Effectors
CA3015702A1 (fr) 2015-09-02 2017-03-09 Trevena, Inc. Aza-heterocyclique a 6 elements contenant des composes modulateurs de recepteurs opioides delta, et leurs procedes de fabrication et d'utilisation
CN108366997A (zh) 2015-12-14 2018-08-03 特维娜有限公司 治疗痛觉过敏的方法
WO2018045369A1 (fr) * 2016-09-05 2018-03-08 BellBrook Labs Test de dépistage à grande capacité
CA3052479A1 (fr) 2017-02-17 2018-08-23 Trevena, Inc. Composes modulateurs du recepteur des opioides delta contenant des heterocycles aza a 7 chainons, et leurs procedes de preparation et d'utilisation
CN110520129A (zh) 2017-02-17 2019-11-29 特维娜有限公司 含有5元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
WO2018237145A1 (fr) 2017-06-21 2018-12-27 Mitokinin, Inc. Compositions et méthodes les utilisant pour le traitement d'une maladie neurodégénérative et mitochondriale
CN112858504A (zh) * 2021-01-08 2021-05-28 苏州国辰生物科技股份有限公司 一种液质联用测定生物体液样品中cGMP浓度的检测方法
WO2023154597A1 (fr) 2022-02-11 2023-08-17 Firmenich Incorporated Cellules exprimant des récepteurs d'umami et leurs utilisations

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"CHEMICAL ABSTRACTS", VOL. 83, NO. 1, 7 JUILLET 1975 PAGE 385, ABREGE NO. 4254 X KATOH, YOSHIKI ET AL. "SIMPLIFIED RADIOIMMUNOASSAY OF ADENOSINE 3', 5'-MONOPHOSPHATE USING DEXTRAN-COATED CHARCOAL") *
CHEMICAL ABSTRACTS", VOL. 76, NO. 15, 10 AVRIL 1972 *
PAGE 207, ABREGE NO. 83.189M A.L.STEINER ET AL. "RADIOIMMUNO ASSAY FOR CYCLIC NUCLEOTIDES I. PREPARATION OF ANTIBODIES AND IODINATES CYCLIC NUCLEOTIDES". *

Also Published As

Publication number Publication date
DE2705897A1 (de) 1977-08-18
US4115538A (en) 1978-09-19
CA1092022A (fr) 1980-12-23
DE2705897C3 (de) 1980-02-28
DE2705897B2 (de) 1979-06-21
GB1527465A (en) 1978-10-04
CH618015A5 (fr) 1980-06-30
JPS52117418A (en) 1977-10-01
JPS5825980B2 (ja) 1983-05-31
FR2341139B1 (fr) 1979-10-05

Similar Documents

Publication Publication Date Title
FR2341139A1 (fr) Trousse de reactifs pour le dosage de l'adenosine-3', 5'-monophosphate cyclique et du guanosine-3', 5'-monophosphate cyclique
BE847598A (fr) Dispositif collecteur d'echantillons,
IT1115552B (it) Procedimento per l'eliminazione selettiva delle lipoproteine dal plasma o siero sanguigno
BE840815A (fr) Dispositif d'echantillonnage
IT1088993B (it) Aeromobile "canard"
FR2413594B1 (fr) Robinet d'arret
IT1101280B (it) Prova immunochimica con l'impiego di reagenti marcati
NO149155C (no) Gyroskopisk instrument
BE848389A (fr) Instrument d'acupressure,
FR2311316A1 (fr) Dispositif d'echantillonnage geometrique
NL7710157A (nl) Ladinggekoppelde aftrekinrichting.
BR7707402A (pt) Ligas de paladio
FR2302232A1 (fr) Stoppeur d'aussiere
FR2307989A1 (fr) Dispositif d'evacuation de fluides
JPS5326320A (en) Analysis of cathecolamine
DK332077A (da) Gyroskopiske instrumenter
GB1548308A (en) Analysis instruments
IT1090730B (it) Composti sostituiti della 2,1,3-benzotiadiazina
BE843184A (fr) Solutions d'iodophores
FR2346706A1 (fr) Moule d'echantillonnage
SE7608417L (sv) 2-klor-n-isopropyl-2',3'-dimetylacetanilid
NL7613882A (nl) Zelfklevende massa's.
BE831251A (fr) Dispositif de prise d'echantillon
SE7801812L (sv) Vagformsyntetiserare
FR2330405A1 (fr) 1'h-androsta (16,17) cyclopentene-3'-ones

Legal Events

Date Code Title Description
ST Notification of lapse